Skip to main content
. 2014 Dec 30;22(1):99–107. doi: 10.1128/CVI.00001-14

FIG 5.

FIG 5

Analysis of 8 anti-PspAR36A MAbs to assess a possible correlation between MAb-dependent complement deposition and their ability to passively protect mice from an otherwise lethal challenge with strain WU2. Each dot represents an anti-PspAR36A MAb. The correlation between in vitro complement deposition and passive protection was highly significant by a parametric Pearson's linear regression correlation analysis (r = 0.8783, P = 0.0041).